Therapeuticsmd Stock Price Patterns
| TXMD Stock | USD 2.21 0.04 1.78% |
Momentum 77
Buy Stretched
Oversold | Overbought |
Wall Street Target Price 5 | Quarterly Revenue Growth 0.433 |
Using TherapeuticsMD hype-based prediction, you can estimate the value of TherapeuticsMD from the perspective of TherapeuticsMD response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards TherapeuticsMD using TherapeuticsMD's stock options and short interest. It helps to benchmark the overall future attitude of investors towards TherapeuticsMD using crowd psychology based on the activity and movement of TherapeuticsMD's stock price.
TherapeuticsMD Implied Volatility | 4.1 |
TherapeuticsMD's implied volatility exposes the market's sentiment of TherapeuticsMD stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if TherapeuticsMD's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that TherapeuticsMD stock will not fluctuate a lot when TherapeuticsMD's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in TherapeuticsMD to buy its stock at a price that has no basis in reality. In that case, they are not buying TherapeuticsMD because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TherapeuticsMD after-hype prediction price | USD 2.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TherapeuticsMD | Build AI portfolio with TherapeuticsMD Stock |
TherapeuticsMD After-Hype Price Density Analysis
As far as predicting the price of TherapeuticsMD at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TherapeuticsMD or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TherapeuticsMD, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TherapeuticsMD Estimiated After-Hype Price Volatility
In the context of predicting TherapeuticsMD's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TherapeuticsMD's historical news coverage. TherapeuticsMD's after-hype downside and upside margins for the prediction period are 0.10 and 9.53, respectively. We have considered TherapeuticsMD's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TherapeuticsMD is dangerous at this time. Analysis and calculation of next after-hype price of TherapeuticsMD is based on 3 months time horizon.
TherapeuticsMD Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as TherapeuticsMD is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TherapeuticsMD backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TherapeuticsMD, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.08 | 7.47 | 0.19 | 0.02 | 4 Events / Month | 6 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.21 | 2.06 | 8.44 |
|
TherapeuticsMD Hype Timeline
TherapeuticsMD is at this time traded for 2.21. The entity has historical hype elasticity of -0.19, and average elasticity to hype of competition of -0.02. TherapeuticsMD is expected to decline in value after the next headline, with the price expected to drop to 2.06. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -8.44%, whereas the daily expected return is at this time at 1.08%. The volatility of related hype on TherapeuticsMD is about 39315.79%, with the expected price after the next announcement by competition of 2.19. About 29.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.98. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TherapeuticsMD had not issued any dividends in recent years. The entity had 1:50 split on the 9th of May 2022. Given the investment horizon of 90 days the next expected press release will be in about 4 days. Check out TherapeuticsMD Basic Forecasting Models to cross-verify your projections.TherapeuticsMD Related Hype Analysis
Having access to credible news sources related to TherapeuticsMD's direct competition is more important than ever and may enhance your ability to predict TherapeuticsMD's future price movements. Getting to know how TherapeuticsMD's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TherapeuticsMD may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRPH | ProPhase Labs | 0.00 | 9 per month | 0.00 | (0.34) | 11.11 | (22.22) | 77.27 | |
| AYTU | Aytu BioScience | (0.13) | 9 per month | 3.73 | 0.03 | 4.69 | (5.94) | 12.75 | |
| BFRI | Biofrontera | 0.01 | 7 per month | 0.00 | (0.03) | 6.76 | (7.59) | 34.13 | |
| PHGE | Biomx Inc | 0.37 | 8 per month | 0.00 | (0.02) | 14.44 | (18.87) | 88.38 | |
| GELS | Gelteq Limited Ordinary | (0.06) | 31 per month | 0.00 | (0.05) | 6.90 | (7.34) | 55.89 | |
| EKSO | Ekso Bionics Holdings | (0.81) | 10 per month | 5.58 | 0.11 | 10.11 | (9.07) | 112.11 | |
| ERNA | Eterna Therapeutics | 0.01 | 5 per month | 0.00 | (0.17) | 6.90 | (7.91) | 41.43 | |
| MPLT | MapLight Therapeutics Common | 0.52 | 2 per month | 4.00 | 0.03 | 8.62 | (7.50) | 39.27 | |
| AMS | American Shared Hospital | (0.01) | 7 per month | 0.00 | (0.05) | 3.81 | (2.76) | 10.96 | |
| PMN | ProMIS Neurosciences | (0.09) | 6 per month | 5.34 | 0.12 | 13.32 | (7.69) | 38.10 |
TherapeuticsMD Additional Predictive Modules
Most predictive techniques to examine TherapeuticsMD price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TherapeuticsMD using various technical indicators. When you analyze TherapeuticsMD charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TherapeuticsMD Predictive Indicators
The successful prediction of TherapeuticsMD stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TherapeuticsMD, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TherapeuticsMD based on analysis of TherapeuticsMD hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TherapeuticsMD's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TherapeuticsMD's related companies. | 2025 | 2026 (projected) | Dividend Yield | 1.03E-4 | 9.2E-5 | Price To Sales Ratio | 6.48 | 6.15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for TherapeuticsMD Stock analysis
When running TherapeuticsMD's price analysis, check to measure TherapeuticsMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TherapeuticsMD is operating at the current time. Most of TherapeuticsMD's value examination focuses on studying past and present price action to predict the probability of TherapeuticsMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TherapeuticsMD's price. Additionally, you may evaluate how the addition of TherapeuticsMD to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |